NCT04853303 is a NA clinical trial of Hypnosis VR in Neoplasms, sponsored by The Hong Kong Polytechnic University.

Who is sponsoring NCT04853303?

NCT04853303 is sponsored by The Hong Kong Polytechnic University.

What drugs are being tested in NCT04853303?

Interventions in NCT04853303: Hypnosis VR.

What condition does NCT04853303 study?

NCT04853303 studies Neoplasms, Child, Nausea, Vomiting, Sleep Hygiene, Pain.

Is NCT04853303 still recruiting?

NCT04853303 is currently status unknown. Last updated 20 May 2021.

Last reviewed 2021-05-20 · How we verify

NCT04853303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK

Status unknown NA Last updated 20 May 2021

What this trial tests

NA trial testing Hypnosis VR in Neoplasms in 180 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
31 January 2025

30 June 2025

Quick facts

Lead sponsor	The Hong Kong Polytechnic University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	180
Start date	1 September 2021
Primary completion	31 January 2025
Estimated completion	30 June 2025

Drugs / interventions tested

Hypnosis VR

Conditions studied

Neoplasms — all drugs for Neoplasms →
Child — all drugs for Child →
Nausea — all drugs for Nausea →
Vomiting — all drugs for Vomiting →

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 9 to 18, any sex, with Neoplasms or Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chemotherapy-induced nausea and vomiting, sleep quality and pain are the common symptoms experienced by children with cancer. These symptoms significantly devastate the children's quality of life. Hypnosis is found to be effective in managing chemotherapy-induced nausea and vomiting, sleep quality and pain in children with cancer. In addition, virtual reality is shown to promote the effectiveness of hypnosis in managing these symptoms. However, no study so far has examine it effectiveness in Hong Kong Chinese children with cancer. This study aims to investigate the effectiveness in the use a virtual reality device to improve chemotherapy-induced nausea and vomiting, sleep quality and pain among children with cancer in Hong Kong.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review.
Comparcini D, Simonetti V, Galli F, Saltarella I, et al · · 2023 · cited 19× · PMID 36765945 · DOI 10.3390/cancers15030985

Verify or expand the search:

Other recruiting trials for Neoplasms

Currently open trials in the same condition.

NCT07438782 — First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combinatio · Phase 1 · recruiting
NCT07382817 — Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms · Phase 1 · recruiting
NCT07277270 — A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tum · Phase 1 · recruiting
NCT07257640 — IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia · Phase 1 · recruiting
NCT07213609 — A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer · Phase 1, PHASE2 · recruiting

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04853303 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
Last refreshed: 20 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04853303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing